Trial Profile
A retrospective analysis of tacrolimus prolonged-release versus tacrolimus twice a day in patients with liver tansplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Therapeutic Use
- 01 Dec 2015 New trial record